BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18797725)

  • 1. Cystic fibrosis and neonatal screening.
    Rodrigues R; Gabetta CS; Pedro KP; Valdetaro F; Fernandes MI; Magalhães PK; Januário JN; Maciel LM
    Cad Saude Publica; 2008; 24 Suppl 4():s475-84. PubMed ID: 18797725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.
    Sommerburg O; Lindner M; Muckenthaler M; Kohlmueller D; Leible S; Feneberg R; Kulozik AE; Mall MA; Hoffmann GF
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S263-71. PubMed ID: 20714932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective and parallel assessments of cystic fibrosis newborn screening protocols in the Czech Republic: IRT/DNA/IRT versus IRT/PAP and IRT/PAP/DNA.
    Krulišová V; Balaščaková M; Skalická V; Piskáčková T; Holubová A; Paděrová J; Křenková P; Dvořáková L; Zemková D; Kračmar P; Chovancová B; Vávrová V; Stambergová A; Votava F; Macek M
    Eur J Pediatr; 2012 Aug; 171(8):1223-9. PubMed ID: 22581207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAP assays in newborn screening for cystic fibrosis: a population-based cost-effectiveness study.
    Seror V; Cao C; Roussey M; Giorgi R
    J Med Screen; 2016 Jun; 23(2):62-9. PubMed ID: 26304152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive neonatal screening for cystic fibrosis in neonates with renal failure.
    Oosterveld MJ; Schilperoort JV; Lilien MR; Arets HG
    Thorax; 2010 Jul; 65(7):652-3. PubMed ID: 20627926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis: refining the approach to newborn screening.
    Wilcken B
    J Pediatr; 2009 Nov; 155(5):605-6. PubMed ID: 19840611
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood concentrations of pancreatitis associated protein in neonates: relevance to neonatal screening for cystic fibrosis.
    Sarles J; Barthellemy S; Férec C; Iovanna J; Roussey M; Farriaux JP; Toutain A; Berthelot J; Maurin N; Codet JP; Berthézène P; Dagorn JC
    Arch Dis Child Fetal Neonatal Ed; 1999 Mar; 80(2):F118-22. PubMed ID: 10325788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populations.
    Sommerburg O; Krulisova V; Hammermann J; Lindner M; Stahl M; Muckenthaler M; Kohlmueller D; Happich M; Kulozik AE; Votava F; Balascakova M; Skalicka V; Stopsack M; Gahr M; Macek M; Mall MA; Hoffmann GF
    J Cyst Fibros; 2014 Jan; 13(1):15-23. PubMed ID: 23891278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between two newborn screening strategies for cystic fibrosis in Argentina: IRT/IRT versus IRT/PAP.
    Teper A; Smithuis F; Rodríguez V; Salvaggio O; Maccallini G; Aranda C; Lubovich S; Zaragoza S; García-Bournissen F
    Pediatr Pulmonol; 2021 Jan; 56(1):113-119. PubMed ID: 33095477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of 47,213 infants in neonatal screening for cystic fibrosis, using pancreatitis-associated protein and immunoreactive trypsinogen assays].
    Barthellemy S; Maurin N; Roussey M; Férec C; Murolo S; Berthézène P; Iovanna JL; Dagorn JC; Sarles J
    Arch Pediatr; 2001 Mar; 8(3):275-81. PubMed ID: 11270251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining immunoreactive trypsinogen and pancreatitis-associated protein assays, a method of newborn screening for cystic fibrosis that avoids DNA analysis.
    Sarles J; Berthézène P; Le Louarn C; Somma C; Perini JM; Catheline M; Mirallié S; Luzet K; Roussey M; Farriaux JP; Berthelot J; Dagorn JC
    J Pediatr; 2005 Sep; 147(3):302-5. PubMed ID: 16182665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High allelic heterogeneity between Afro-Brazilians and Euro-Brazilians impacts cystic fibrosis genetic testing.
    Raskin S; Pereira L; Reis F; Rosario NA; Ludwig N; Valentim L; Phillips JA; Allito B; Heim RA; Sugarman EA; Probst CM; Faucz F; Culpi L
    Genet Test; 2003; 7(3):213-8. PubMed ID: 14641997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systematic neonatal screening].
    Guillot M; Travert G; Roussey M; Figarella C; Vidailhet M
    Arch Pediatr; 2001 Dec; 8 Suppl 5():833s-837s. PubMed ID: 11811052
    [No Abstract]   [Full Text] [Related]  

  • 14. [National program for neonatal screening for cystic fibrosis: implementation and preliminary results].
    Navarro J; Grosskopf C; Vidailhet M; Briard ML; Farriaux JP
    J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1 Suppl):1S56-60. PubMed ID: 12592165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five years of experience with biochemical cystic fibrosis newborn screening based on IRT/PAP in Germany.
    Sommerburg O; Hammermann J; Lindner M; Stahl M; Muckenthaler M; Kohlmueller D; Happich M; Kulozik AE; Stopsack M; Gahr M; Hoffmann GF; Mall MA
    Pediatr Pulmonol; 2015 Jul; 50(7):655-64. PubMed ID: 25914230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?
    Scotet V; Audrézet MP; Roussey M; Rault G; Dirou-Prigent A; Journel H; Moisan-Petit V; Storni V; Férec C
    Pediatrics; 2006 Nov; 118(5):e1523-9. PubMed ID: 17015492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal screening for cystic fibrosis: comparing the performances of IRT/DNA and IRT/PAP.
    Sarles J; Giorgi R; Berthézène P; Munck A; Cheillan D; Dagorn JC; Roussey M
    J Cyst Fibros; 2014 Jul; 13(4):384-90. PubMed ID: 24513262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations.
    Padoan R; Bassotti A; Seia M; Corbetta C
    Eur J Pediatr; 2002 Apr; 161(4):212-5. PubMed ID: 12014388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic Fibrosis Diagnosis and Newborn Screening.
    Rosenfeld M; Sontag MK; Ren CL
    Pediatr Clin North Am; 2016 Aug; 63(4):599-615. PubMed ID: 27469178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal screening for the cystic fibrosis main mutation delta F508 in Estonia.
    Klaassen T; Teder M; Viikmaa M; Metspalu A
    J Med Screen; 1998; 5(1):16-9. PubMed ID: 9575453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.